NCT06912763: Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
- State
- Under way
- Phase
- Phase 2
- People
- 250 planned
- Started
- 8 Aug 2025
- Primary completion
- 31 Jul 2030
- Arms
- Treatment with SoC (Control)
- Results
- None posted
- 6 Apr 2025: Trial registered
- 8 Aug 2025: Trial started